NOVN:SWX
Novartis AG
CHF 112.20
arrow_upward
+0.05%(+0.060) 1D
Sep 11, 4:24:59 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVN...
Open
CHF 112.50
High
CHF 113.70
Low
CHF 112.12
Mkt. cap
228.31B
Avg. vol.
2.57M
Volume
1.62M
Dividend
3.30%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
20.94
52-wk high
CHF 132.68
52-wk low
CHF 96.03
EPS
CHF 5.36
Shares outstanding
2.03B
No. of employees
75K
Open
CHF 112.50
High
CHF 113.70
Low
CHF 112.12
Mkt. cap
228.31B
Avg. vol.
2.57M
Volume
1.62M
Dividend
3.30%
Quarterly dividend
CHF 0.93
Ex-dividend date
Mar 10, 2026
P/E ratio
20.94
52-wk high
CHF 132.68
52-wk low
CHF 96.03
EPS
CHF 5.36
Shares outstanding
2.03B
No. of employees
75K
News stories
From web sources and news partners
Pharmaceutical Executive
·
11 minutes ago
Novartis Investor's Share Concerns Over M&A Strategy: Report
BioSpace
·
49 minutes ago
Novartis drags peers down with triple asset stumble
Yahoo Finance
·
1 hour ago
Top Investor Urges Novartis for Stronger Acquisition Oversight After M&A and Trial Setbacks
ad-hoc-news.de
·
1 hour ago
Novartis stock falls on trial setbacks as Berenberg cuts price target
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com